1
|
Wei C, Wen H, Yuan L, McHale CM, Li H,
Wang K, Yuan J, Yang X and Zhang L: Formaldehyde induces toxicity
in mouse bone marrow and hematopoietic stem/progenitor cells and
enhances benzene-induced adverse effects. Arch Toxicol. 91:921–933.
2017. View Article : Google Scholar : PubMed/NCBI
|
2
|
IARC (International agency for Research on
Cancer), . A review of human carcinogens: Chemical agents and
related occupations: Formaldehyde. Monographs on the Evaluation of
Carcinogenic Risks to Humans 100F. 401–435. 2012.
|
3
|
NTP (National Toxicology Program), .
Report on carcinogens, 12th edition. National Toxicology Program.
195–205. 2011.
|
4
|
Renström J, Kröger M, Peschel C and
Oostendorp RA: How the niche regulates hematopoietic stem cells.
Chem Biol Interact. 184:7–15. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Kim G, Ouzounova M, Quraishi AA, Davis A,
Tawakkol N, Clouthier SG, Malik F, Paulson AK, D'Angelo RC, Korkaya
S, et al: SOCS3-mediated regulation of inflammatory cytokines in
PTEN and p53 inactivated triple negative breast cancer model.
Oncogene. 34:671–680. 2015. View Article : Google Scholar : PubMed/NCBI
|
6
|
Santanam U, Banach-Petrosky W, Abate-Shen
C, Shen MM, White E and DiPaola RS: Atg7 cooperates with Pten loss
to drive prostate cancer tumor growth. Genes Dev. 30:399–407. 2016.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Mendes RD, Canté-Barrett K, Pieters R and
Meijerink JP: The relevance of PTEN-AKT in relation to
NOTCH1-directed treatment strategies in T-cell acute lymphoblastic
leukemia. Haematologica. 101:1010–1017. 2016. View Article : Google Scholar : PubMed/NCBI
|
8
|
Tesio M, Oser GM, Baccelli I, Blanco-Bose
W, Wu H, Göthert JR, Kogan SC and Trumpp A: Pten loss in the bone
marrow leads to G-CSF-mediated HSC mobilization. J Exp Med.
210:2337–2349. 2013. View Article : Google Scholar : PubMed/NCBI
|
9
|
Choorapoikayil S, Kers R, Herbomel P,
Kissa K and den Hertog J: Pivotal role of Pten in the balance
between proliferation and differentiation of hematopoietic stem
cells in zebrafish. Blood. 123:184–190. 2014. View Article : Google Scholar : PubMed/NCBI
|
10
|
Fransecky L, Mochmann LH and Baldus CD:
Outlook on PI3K/AKT/mTOR inhibition in acute leukemia. Mol Cell
Ther. 3:22015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Faes S and Dormond O: PI3K and AKT:
Unfaithful partners in cancer. Int J Mol Sci. 16:21138–21152. 2015.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Follo MY, Manzoli L, Poli A, McCubrey JA
and Cocco L: PLC and PI3K/Akt/mTOR signalling in disease and
cancer. Adv Bio Regul. 57:10–16. 2015. View Article : Google Scholar
|
13
|
Ferenc P, Solár P, Kleban J, Mikes J and
Fedorocko P: Down-regulation of Bcl-2 and Akt induced by
combination of photoactivated hypericin and genistein in human
breast cancer cells. J Photochem Photobiol B. 98:25–34. 2010.
View Article : Google Scholar : PubMed/NCBI
|
14
|
NIH (National Institutes of Health USA), .
Guide for the care and use of laboratory animals (8th edition).
Washington (DC): National Academies Press (US); 2011
|
15
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Li X, Xie W, Xie C, Huang C, Zhu J, Liang
Z, Deng F, Zhu M, Zhu W, Wu R, et al: Curcumin modulates
miR-19/PTEN/AKT/p53 axis to suppress bisphenol A-induced MCF-7
breast cancer cell proliferation. Phytother Res. 28:1553–1560.
2014. View
Article : Google Scholar : PubMed/NCBI
|
17
|
Nuciforo PG, Aura C, Holmes E, Prudkin L,
Jimenez J, Martinez P, Ameels H, de la Peña L, Ellis C, Eidtmann H,
et al: Benefit to neoadjuvant anti-human epidermal growth factor
receptor 2 (HER2)-targeted therapies in HER2-positive primary
breast cancer is independent of phosphatase and tensin homolog
deleted from chromosome 10 (PTEN) status. Ann Oncol. 26:1494–1500.
2015. View Article : Google Scholar : PubMed/NCBI
|
18
|
Krohn A, Freudenthaler F, Harasimowicz S,
Kluth M, Fuchs S, Burkhardt L, Stahl P, C Tsourlakis M, Bauer M,
Tennstedt P, et al: Heterogeneity and chronology of PTEN deletion
and ERG fusion in prostate cancer. Mod Pathol. 27:1612–1620. 2014.
View Article : Google Scholar : PubMed/NCBI
|
19
|
Zhu G, Chai J, Ma L, Duan H and Zhang H:
Downregulated microRNA-32 expression induced by high glucose
inhibits cell cycle progression via PTEN upregulation and Akt
inactivation in bone marrow-derived mesenchymal stem cells. Biochem
Biophys Res Commun. 433:526–531. 2013. View Article : Google Scholar : PubMed/NCBI
|
20
|
Ye X, Ji Z, Wei C, McHale CM, Ding S,
Thomas R, Yang X and Zhang L: Inhaled formaldehyde induces
DNA-protein crosslinks and oxidative stress in bone marrow and
other distant organs of exposed mice. Environ Mol Mutagen.
54:705–718. 2013. View
Article : Google Scholar : PubMed/NCBI
|
21
|
Chang F, Lee JT, Navolanic PM, Steelman
LS, Shelton JG, Blalock WL, Franklin RA and McCubrey JA:
Involvement of PI3K/Akt pathway in cell cycle progression,
apoptosis, and neoplastic transformation: A target for cancer
chemotherapy. Leukemia. 17:590–603. 2003. View Article : Google Scholar : PubMed/NCBI
|
22
|
Whitfield ML, Sherlock G, Saldanha AJ,
Murray JI, Ball CA, Alexander KE, Matese JC, Perou CM, Hurt MM,
Brown PO and Botstein D: Identification of genes periodically
expressed in the human cell cycle and their expression in tumors.
Mol Biol Cell. 13:1977–2000. 2002. View Article : Google Scholar PubMed/NCBI
|
23
|
Williams GH and Stoeber K: The cell cycle
and cancer. J Pathol. 226:352–364. 2012. View Article : Google Scholar : PubMed/NCBI
|
24
|
Jing X, Cheng W, Wang S, Li P and He L:
Resveratrol induces cell cycle arrest in human gastric cancer
MGC803 cells via the PTEN-regulated PI3K/Akt signaling pathway.
Oncol Rep. 35:472–478. 2016. View Article : Google Scholar : PubMed/NCBI
|
25
|
Weng L, Brown J and Eng C: PTEN induces
apoptosis and cell cycle arrest through
phosphoinositol-3-kinase/Akt-dependent and -independent pathways.
Hum Mol Genet. 10:237–242. 2001. View Article : Google Scholar : PubMed/NCBI
|
26
|
Rahmani M, Aust MM, Attkisson E, Williams
DC Jr, Ferreira-Gonzalez A and Grant S: Dual inhibition of Bcl-2
and Bcl-xL strikingly enhances PI3K inhibition-induced apoptosis in
human myeloid leukemia cells through a GSK3- and Bim-dependent
mechanism. Cancer Res. 73:1340–1351. 2013. View Article : Google Scholar : PubMed/NCBI
|
27
|
Vachhani P, Bose P, Rahmani M and Grant S:
Rational combination of dual PI3K/mTOR blockade and Bcl-2/-xL
inhibition in AML. Physiol Genomics. 46:448–456. 2014. View Article : Google Scholar : PubMed/NCBI
|